H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while ...

On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating. This revision follows a revenue ...

On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating. This revision follows a revenue ...

Thank you for standing by. And welcome to Invivyd’s First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there ...

INVIVYD ($IVVD) posted quarterly earnings results on Thursday, May 15th. The company reported earnings of -$0.14 per share, missing estimates of -$0.03 by $0.11. The ...

Potential Non-Dilutive Funding: Up to $30 million through a term loan facility with SVB. Invivyd Inc (NASDAQ:IVVD) has internalized its commercial organization, which is expected to drive broader ...

INVIVYD ($IVVD) is expected to release its quarterly earnings data on Thursday, May 15th before market open, per Finnhub. Analysts are expecting revenue of ...

View Our Latest Research Report on Invivyd Invivyd Trading Up 12.0% Shares of NASDAQ IVVD opened at $0.95 on Friday. The company has a market cap of $113.93 million, a price-to-earnings ratio of ...

WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that ...